Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.
暂无分享,去创建一个
B. Xiao | Junming Guo | Zhaohui Gong | Yanping Le | Mi Zhou | Disen Mei | Qiong Liu | Lin Pan | Shaomin Wang | Xiang'e Long
[1] S. Rhee,et al. An efficient plasmid vector for constitutive high-level expression of foreign genes in Escherichia coli , 2009, Biotechnology Letters.
[2] M. Gómez-Lim,et al. Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli , 2009, Virology Journal.
[3] Tae-Geum Kim,et al. Immunogenicity of a Cholera Toxin B Subunit Porphyromonas gingivalis Fimbrial Antigen Fusion Protein Expressed in E. coli , 2009, Molecular biotechnology.
[4] T. Mor,et al. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. , 2009, Plant biotechnology journal.
[5] C. Betterle,et al. Preparation and Testing of Diabetes Autoantibody Controls , 2008, Annals of the New York Academy of Sciences.
[6] S. Ramalingam,et al. Rare codon priority and its position specificity at the 5' of the gene modulates heterologous protein expression in Escherichia coli. , 2008, Biochemical and biophysical research communications.
[7] Johnny Ludvigsson,et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. , 2008, The New England journal of medicine.
[8] Amit Ghosh,et al. Expression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). , 2008, Journal of biotechnology.
[9] Amit Ghosh,et al. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum) , 2008, Plant Cell Reports.
[10] Tracey A Ruhlman,et al. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice. , 2007, Plant biotechnology journal.
[11] T. Park,et al. Expression of recombinant human growth hormone in a soluble form in Escherichia coli by slowing down the protein synthesis rate. , 2007, Journal of microbiology and biotechnology.
[12] Yongfeng Jin,et al. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm. , 2007, Vaccine.
[13] Tae-Geum Kim,et al. Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. , 2006, Protein expression and purification.
[14] A. Jevnikar,et al. Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants , 2006, Plant Cell Reports.
[15] M. Estes,et al. Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato , 2005, Molecular biotechnology.
[16] Yongfeng Jin,et al. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes. , 2005, Journal of biotechnology.
[17] S. Michalek,et al. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. , 2005, Vaccine.
[18] A. Jevnikar,et al. Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Petersen,et al. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes , 2003, Clinical and experimental immunology.
[20] J. Petersen,et al. The Cholera Toxin B Subunit is a Mucosal Adjuvant for Oral Tolerance Induction in Type 1 Diabetes , 2003, Scandinavian journal of immunology.
[21] C. Czerkinsky,et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA , 2003, Expert review of vaccines.
[22] C. Czerkinsky,et al. Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses 1 , 2003, The Journal of Immunology.
[23] P. Ho,et al. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. , 2002, Protein expression and purification.
[24] E. Sercarz,et al. Regulatory and Effector CD4 T Cells in Nonobese Diabetic Mice Recognize Overlapping Determinants on Glutamic Acid Decarboxylase and Use Distinct Vβ Genes1 , 2001, The Journal of Immunology.
[25] H. Weiner,et al. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. , 2001, Journal of autoimmunity.
[26] M. Isaka,et al. Cytokine Responses to Recombinant Cholera Toxin B Subunit Produced by Bacillus brevis as a Mucosal Adjuvant , 2001, Microbiology and immunology.
[27] C. Czerkinsky,et al. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit. , 2000, Clinical immunology.
[28] C. Czerkinsky,et al. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[29] Keisuke Sato,et al. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice , 2000, Immunogenetics.
[30] H. Kolb,et al. Induction of Tolerance in Macrophages by Cholera Toxin B Chain , 2000, Pathobiology.
[31] N. Glaichenhaus,et al. Selective tolerization of Th1‐like cells after nasal administration of a cholera toxoid‐LACK conjugate , 1998, European journal of immunology.
[32] A. Jevnikar,et al. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance , 1997, Nature Medicine.
[33] J. Petersen,et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Li,et al. Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone. , 1996, International immunology.
[35] T. Olsson,et al. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Atkinson,et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes , 1996, The Journal of experimental medicine.
[37] H. Weiner,et al. Oral tolerance , 2011, Immunological reviews.
[38] C. Czerkinsky,et al. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] H. Bazin,et al. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit , 1992, European journal of immunology.
[40] Th. Mandel,et al. Progression From Insulitis to β-Cell Destruction in NOD Mouse Requires L3T4+ T-Lymphocytes , 1988, Diabetes.
[41] S. Korban,et al. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. , 2009, The Plant journal : for cell and molecular biology.
[42] R. Uibo,et al. GAD65 autoimmunity-clinical studies. , 2008, Advances in immunology.
[43] Alfred D. Eaton,et al. Oral tolerance. , 2000, American journal of respiratory and critical care medicine.